Form 4 Tracker
Elena Ridloff

CFO and CBO; Director · 5 filings · Latest: Sep 17, 2026

IMMUNIC, INC.
Kymera Therapeutics, Inc.
Sionna Therapeutics, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
KYMR
Elena RidloffDirectorMay 11, 2026
Sale
$87.003,000$261.0K0
KYMR
Elena RidloffDirectorMay 11, 2026
Option Exercise
$31.203,000$93.6K3,000
KYMR
ELENA RIDLOFF—May 11, 2026
Proposed Sale
$86.083,000$258.2K—
KYMR
Elena RidloffDirectorApr 1, 2026
Sale
$85.424,600$392.9K0
KYMR
Elena RidloffDirectorApr 1, 2026
Option Exercise
$14.184,600$65.2K4,600
KYMR
Elena RidloffDirectorMar 31, 2026
Sale
$85.377,400$631.7K0
KYMR
Elena RidloffDirectorMar 31, 2026
Option Exercise
$14.187,400$104.9K7,400
KYMR
ELENA RIDLOFF—Apr 1, 2026
Proposed Sale
$83.294,600$383.1K—
KYMR
ELENA RIDLOFF—Mar 31, 2026
Proposed Sale
$79.487,400$588.2K—
SION
ELENA RIDLOFF—Aug 26, 2025
Proposed Sale
$24.0633,000$794.0K—
SION
ELENA RIDLOFF—Aug 20, 2025
Proposed Sale
$21.4817,500$375.9K—
SION
ELENA RIDLOFF—Aug 19, 2025
Proposed Sale
$21.3934,500$738.0K—
KYMR
ELENA RIDLOFF—Jun 11, 2025
Proposed Sale
$48.604,500$218.7K—
KYMR
ELENA RIDLOFF—Jun 3, 2025
Proposed Sale
$43.1312,000$517.6K—